Karbicombi 16 mg/12,5 mg tablete
| Name | Karbicombi 16 mg/12,5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-043497579 |
| Active Substance | kandesartancileksetil hidroklorotiazid |
| Composition | jedna tableta sadrži 16 mg kandesartancileksetila i 12,5 mg hidroklorotiazida |
| Pharmaceutical Form | tableta |
| Manufacturer | Krka d.d., Novo mesto, Novo Mesto, Slovenija |
| Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
| Marketing Authorisation Date | 07.12.2021 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/531 |
| Registration Number | 381-12-01/14-21-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09DA06 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
